Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hauschke

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
British Journal of Pharmacology|August 28, 1998
Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndromeD Häfner, P G Germann, D Hauschke
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43E Diletti, D Hauschke, V W Steinijans
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2000
Characterisation of the rat lung lavage model as biological assay for testing the activity of surfactant preparationsD Häfner, M Burke, K Schick, et al.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1991
Density of gastroendocrine cells in cynomolgus monkey and other speciesK Tuch, D Ockert, U Hübel, et al.
Pulmonary Pharmacology & Therapeutics|July 27, 1999
Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injuryD Häfner, P G Germann, D Hauschke, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1992
Sample size determination for bioequivalence assessment using a multiplicative modelD Hauschke, V W Steinijans, E Diletti, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 1, 1994
Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulationsR Schall, H G Luus, V W Steinijans, et al.
Journal of Clinical Pathology|October 21, 2011
Aurora-B protein expression is linked to initial response to taxane-based first-line chemotherapy in stage III ovarian carcinomaS Beussel, A Hasenburg, L Bogatyreva, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|February 8, 2000
Intratracheally applied rSP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model of acute lung hypersensitivityP G Germann, J Kemkowski, D Hauschke, et al.
Der Anaesthesist|October 1, 1985
[Accuracy of halothane vaporizers with respect to temperature, carrier gas composition and gas flow rate]H Rieke, E M Raffauf, K Züchner, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
British Journal of Pharmacology|August 28, 1998
Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndromeD Häfner, P G Germann, D Hauschke
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1992
Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43E Diletti, D Hauschke, V W Steinijans
Journal of Pharmaceutical and Biomedical Analysis|March 7, 2000
Characterisation of the rat lung lavage model as biological assay for testing the activity of surfactant preparationsD Häfner, M Burke, K Schick, et al.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1991
Density of gastroendocrine cells in cynomolgus monkey and other speciesK Tuch, D Ockert, U Hübel, et al.
Pulmonary Pharmacology & Therapeutics|July 27, 1999
Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injuryD Häfner, P G Germann, D Hauschke, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1992
Sample size determination for bioequivalence assessment using a multiplicative modelD Hauschke, V W Steinijans, E Diletti, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 1, 1994
Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulationsR Schall, H G Luus, V W Steinijans, et al.
Journal of Clinical Pathology|October 21, 2011
Aurora-B protein expression is linked to initial response to taxane-based first-line chemotherapy in stage III ovarian carcinomaS Beussel, A Hasenburg, L Bogatyreva, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|February 8, 2000
Intratracheally applied rSP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model of acute lung hypersensitivityP G Germann, J Kemkowski, D Hauschke, et al.
Der Anaesthesist|October 1, 1985
[Accuracy of halothane vaporizers with respect to temperature, carrier gas composition and gas flow rate]H Rieke, E M Raffauf, K Züchner, et al.
Pageof 5